Arovella Therapeutics (ASX:ALA) - Key People

ASX:ALA · Directors, executives and key personnel · 12 month lookback

Dr Michael Baker Current

Chief Executive Officer & Managing Director

Mentioned in

Healthcare Wrap - Week 31 (27 July -> 31 July) 2026

1 Aug 2026

Arovella Advances CAR-iNKT Trials with $14.4 Million Cash Backing

27 July 2026

Healthcare Wrap - Week 19 (4 May -> 8 May) 2026

9 May 2026

Arovella Appoints Nicole Van Der Weerden as Acting CEO Ahead of Key Trial

7 May 2026

+16 more articles →

Also Mentioned

People named in Arovella Therapeutics (ASX:ALA) articles over the last 12 months, by frequency.

Andrew Nash · 8 articles David Williams · 6 articles Debora Barton · 6 articles Nicole van der Weerden · 5 articles Mike Perry · 4 articles Michael Thurn · 4 articles Mark Diamond · 4 articles Professor Gianpietro Dotti · 4 articles Elizabeth Stoner · 3 articles Professor Cameron Turtle · 2 articles Salvatore Fiorenza · 2 articles Gary Phillips · 2 articles Tim Lusco · 2 articles Lachlan Mallia · 2 articles B G McVeigh · 2 articles Thomas Duthy · 1 article